Primary Peritoneal Carcinoma Completed Phase 2 Trials for Paclitaxel (DB01229)

IndicationStatusPhase
DBCOND0028874 (Primary Peritoneal Carcinoma)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00045682CT-2103 in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer or Primary Peritoneal CancerTreatment
NCT00407563Bevacizumab With Abraxane in Patients With Recurrent Ovarian/ Peritoneal CancerTreatment
NCT00499252Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal CancerTreatment
NCT00561795Feasibility Study of Pazopanib in Combination With Chemotherapy in Gynaecological TumorsTreatment